维普中文期刊产品整合服务
12篇 您的检索式:作者名="TESSIER PR"
    题名 作者 年代 出处 被引量
1In vivo comparison of CXA-101 ( FR264205 ) with and without tazobactam versus piperacillin-tazobactam using human simulated exposures against phenotypically diverse gram-negative organisms显示文摘BULIK CC TESSIER PR KEEL RA 2012Antimicrob Agents Chemother2012,56,1:1
2Tigecycline displays in vivo bacteri- cidal activity against extended-spectrum-β-lactamase-produ- cing Enterobacteriaceae after 72-hour exposure period 显示文摘Tessier PR Nicolau DP 2013Antimicrob Agents Chemother2013,57,1:1
3Comparison of bronchopulmonary pharmacokinetics ofclarithromycin and azithromycin显示文摘Patel KB Xuan D Tessier PR 1996Antimicrob Agents Chemother1996,40,10:1
4Comparative in vivo efficacy of meropenem, imipenem and cefepime against pseudomonas aeruginosa expressing Mex A, Mex B, Opr M efflux pumps 显示文摘Ong CT Tessier PR Li C 2007Diagn Microbiol Infect Dis2007,57,2:1
5Pharmacodynamics of intermittent-and continuous-infusion cefepime alone and in combination with once-daily tobramycin against Pseudomonas aeruginosa in an in vitro infection model显示文摘Tessier PR Nicolau DP Onyeji CO 1999Chemotherapy1999,45,:1
6In vivo comparison of CXA-101 (FR264205) with and without tazobactam versus piperacillin-tazobactam using human simulated exposures against phenotypicaUy diverse Gram-negative organisms 显示文摘Bulik CC Tessier PR Keel RA 2012Antimicrob Agents Chemother2012,56,:1
7Comparison of bronchopulmonary pharmacokinetics of clarithromycin and azithromycin 显示文摘Patel KB Xuan D Tessier PR 1996Antimicrob Agents Chemother1996,40,10:1
8Comparative in vivo efficacy of meropenem, imipenem, and cefepime against Pseudomonas aeruginosa expressing MexA-MexB-OprM efflux pumps显示文摘Ong CT Tessier PR Li C 2007Diagn Microbiol Infect Dis2007,57,2:1
9Comparative in vivo efficacy of meropen- em, imipenem and cefepime against pseudomonas aeruginosa expressing Mex A, Mex B, Opr M efflux pumps 显示文摘Ong CT Tessier PR Li C 2007Diagn Microbiol Infect Dis2007,57,2:1
10Comparison of vancomycin pharmacodynamics (1 g every 12 or 24 h) against methicillin-resistant staphylococci显示文摘Lacy MK Tessier PR Nicolau DP 2000Int J A ntimicrob Agents2000,15,1:1
11Invitro reduction of immunoglobulin G显示文摘Xuan D Nicolau DP Tessier PR 1997Antinicrolo Agents Chemother1997,41,7:1
12Comparison of vancomycin pharmacodynamics (1 g every 12 or 24 h) against methicillin- resistant staphylococci显示文摘LACY MK TESSIER PR NICOLAU DP et ol 2000Int J Antimicrob Agents2000,15,1:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费